Document is current
Any future updates will be listed below
-
Authors
Dimitriadis, Konstantinos https://orcid.org/0000-0003-0417-2267
Meis, Jan
Neugebauer, Hermann
Barlinn, Kristian
Neumann, Bernhard
Gahn, Georg
Lochner, Piergiorgio
Knier, Benjamin
Lindemann, Sarah
Sühs, Kurt Wolfram
Szabo, Kristina
Pfefferkorn, Thomas
Schirotzek, Ingo
Freilinger, Tobias
Burc, Bassa
Günther, Albrecht
Wittstock, Matthias
Schramm, Patrick
Reimann, Gernot
Godau, Jana
Nagy, Gabor
Koenig, Fatima B.
Essig, Fabian
Klinker, Hartwig
Hartmann, Christian
Schmidbauer, Moritz L.
Steinberg, Tim
Lefterova, Lora
Klose, Christina
Bösel, Julian
,
-
Funding
Funding for this research was provided by:
Study support from the German neurocritical care society: DGNI und personal funds to Julian Bösel
Universitätsklinik München
- License Information
-
More Information
Article History
Received: 13 March 2022
Accepted: 29 June 2022
First Online: 16 July 2022
Declarations
:
: Local ethics committees and institutional review boards of the participating centers approved the study based on the central vote of the ethics committee of Landesärztekammer Hessen, Germany (state medical association, 2020-1619-evBO, ethikkommission@laekh.de). Adult Consent To Participate Written and Human Accordance Statement: The ethics committees waived the requirement to obtain informed consent.
: Not applicable.
: Following conflicts of interests are reported: Albrecht Günther received speaker’s honoraria from Boehringer Ingelheim, Daiichi Sankyo, Pfizer, and Ipsen. Matthias Wittstock received speaker’s honoraria and consulting fees from Boehringer Ingelheim, Bayer Vital and Alexion pharma Germany. All other authors declare that they have no competing interests.
